Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases
Alejandro Quintero-Villegas, Sergio Iván Valdés‐Ferrer
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
Ana Salomé Correia, Armando Cardoso, Nuno Vale
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2081-2081
Open Access | Times Cited: 48
Genus Paeonia monoterpene glycosides: A systematic review on their pharmacological activities and molecular mechanisms
Shiyi Xu, Huiyan Cao, Rui-hong Yang, et al.
Phytomedicine (2024) Vol. 127, pp. 155483-155483
Closed Access | Times Cited: 17
Latest updates on the serotonergic system in depression and anxiety
Jianwen Lin, Wenxin Liu, Jing Guan, et al.
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 13
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2070-2070
Open Access | Times Cited: 15
Synthesis, Pharmacological Characterization, and Binding Mode Analysis of 8-Hydroxy-Tetrahydroisoquinolines as 5-HT7 Receptor Inverse Agonists
Camilla B. Chan, Eline Pottie, Ícaro A. Simon, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT7 and κ‐opioid receptors' molecular interactions and isosteric replacement
Giuseppe Floresta, Alberto Granzotto, Vincenzo Patamia, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Open Access
DRN-SNc serotonergic circuit drives stress-induced motor deficits and Parkinson’s disease vulnerability
Yibo Yao, Chi Cui, Yulong Shi, et al.
Neuropsychopharmacology (2025)
Closed Access
Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms
Damian Kułaga, Anna K. Drabczyk, Przemysław Zaręba, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117995-117995
Closed Access
Monoamine signaling and neuroinflammation: mechanistic connections and implications for neuropsychiatric disorders
Shalini Saggu, Andrew Pless, Emily Dew, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
Dmitrii V Eremin, Е. М. Кондаурова, Aleksander Ya Rodnyy, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 12-13, pp. 2023-2042
Closed Access | Times Cited: 10
Targeting 5-HT Is a Potential Therapeutic Strategy for Neurodegenerative Diseases
Cencan Xing, Hongyu Chen, Wangyu Bi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13446-13446
Open Access | Times Cited: 2
Biological studies of clavine alkaloids targeting CNS receptors
Nikhil R. Tasker, Ethan J. Pazur, Peter Wipf
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Designing multi-target drugs for the treatment of major depressive disorder
Amit Kumar Halder, Soumya Mitra, M. Natália D. S. Cordeiro
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 6, pp. 643-658
Closed Access | Times Cited: 4
Alterations of synaptic plasticity in Angelman syndrome model mice are rescued by 5-HT7R stimulation
Amelia Pizzella, Eduardo Penna, Yan Liu, et al.
Progress in Neurobiology (2024) Vol. 242, pp. 102684-102684
Open Access | Times Cited: 1
Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1G93A Mice Models Uncover Potential Drug Treatments for ALS
Elif Kubat Öktem, Büşra Aydın, Metin Yazar, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 11, pp. 2360-2376
Closed Access | Times Cited: 6
Anticholinesterase and Serotoninergic Evaluation of Benzimidazole–Carboxamides as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
Daria A. Belinskaia, Polina A. Voronina, Д. В. Криворотов, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2159-2159
Open Access | Times Cited: 3
Synthesis, computational simulations and biological evaluation of new dual 5HT1A/5HT7 receptor ligands based on purine-2,6-dione scaffold
Agnieszka Zagórska, Anna Partyka, Magdalena Jastrzębska‐Więsek, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106737-106737
Open Access | Times Cited: 2
T Lymphocyte Serotonin 5-HT7 Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients
Flora Reverchon, Colleen Guillard, Lucile Mollet, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2418-2418
Open Access | Times Cited: 4
The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence
Yang Lu, Yanfei Cheng, Yicheng Zhu, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2387-2414
Closed Access | Times Cited: 2
Neuroprotective and Neurite Outgrowth Stimulating Effects of New Low-Basicity 5-HT7 Receptor Agonists: In Vitro Study in Human Neuroblastoma SH-SY5Y Cells
Klaudia Jakubowska, Adam S. Hogendorf, Sławomir Gołda, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 2179-2196
Open Access
Elevated Cellular Uptake of Succinimide- and Glucose-Modified Liposomes for Blood–Brain Barrier Transfer and Glioblastoma Therapy
Larissa J. Lubitz, Moritz P. Haffner, Harden Rieger, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2135-2135
Open Access
Association between small intestine bacterial overgrowth and psychiatric disorders
Bartosz Bogielski, Katarzyna Michalczyk, Piotr Głodek, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential
Carolina Echeverry, Mariana Pazos, Maximiliano Torres-Pérez, et al.
Neuroscience (2024)
Closed Access
The 5-HT7 receptors in the VLO contribute to the development of morphine-induced behavioral sensitization in rats
Jing‐Si Yang, Feifei Gao, Xixi Yang, et al.
Neurochemistry International (2023) Vol. 168, pp. 105566-105566
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top